Toronto, Ontario--(Newsfile Corp. - April 19, 2022) - City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), trading through the facilities of the Canadian Securities Exchange ("CSE") under the symbol "CVGR" and on the OTCQB^® under the symbol "CVGRF", is pleased to announce that its line of Pawsperity™ hemp formulated dog treats will be carried by PETVALU, Canada's largest pet specialty retailer with over 600 stores coast to coast.

The 100% natural dog treats comprise the initial items in the company's pet supplement range and are positioned to support both active and older dog's wellness, based on the benefits of hemp hearts and other active ingredients. Hemp's nutritional benefits make it one of the world's leading superfoods. Hemp hearts are a rich source of complete plant protein, Omega 3's, Fibre, Vitamin E and beneficial minerals - vital to promote overall nutrition, muscle development and immune system function. The anti-inflammatory properties support healthy heart, coat, skin and joint mobility. Pawsperity™ with Hemp Hearts are available in two formulas: Healthy Active Living Support with added Vitamin B, and Hip and Joint Support with added Turmeric.

Consumer's take their cues for healthy feeding of their dogs from functional food trends. The benefits of Hemp Hearts are well documented and particularly relevant for millennials who are big users of Hemp Heart super foods and now the largest dog owning cohort in Canada.

Rob Fia, CEO of City View Green Holdings Inc., stated:

"We are excited to partner with Canada's leading pet specialty retailer with over 600 stores, including PETVALU, Bosley's, Total Pet and Tisol Pet Nutrition & Supply. The partnership will provide a strong foundation for the establishment of our Pawsperity™ pet brand and the mission of building hemp based and cannabis foods that provide functional benefits for pets and humans. We invite our investors to look for our Pawsperity™ products at a PETVALU store near you."

For further information contact:
City View Green Holdings Inc.
Rob Fia, CEO & President
Email: rob@cityviewgreen.ca
Follow us on Twitter: https://twitter.com/cityviewgreen1

 Neither the Canadian Securities Exchange nor its regulations services accept responsibility for the adequacy or accuracy of this release.

About City View

City View is a leading consumer packaged goods company focused on the development of cannabis-infused edibles. With the receipt of its Cannabis Act processing licence on April 30, 2021, City View will incorporate cannabis-infused food production at its Brantford, Ontario high-capacity facility. In addition, City View owns a 27.5% stake in Budd Hutt Inc. ("Budd Hutt"), a retail-focused cannabis company with access to cannabis cultivation and production licences in Alberta and other retail opportunities across Canada. Through its relationship with Budd Hutt, the Company anticipates securing shelf space, product placement, and distribution opportunities for our white label partner products. For more information visit: www.cityviewgreen.ca.

Disclaimer for Forward-Looking Information

This press release contains forward-looking statements which are not composed of historical facts. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements include estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as "believes", "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan". Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management's expectations. There are a number of important factors that could cause the Company's actual results to differ materially from those indicated or implied by forward-looking statements and information. When relying on the Company's forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Important factors that could cause actual results to differ materially from the Company's expectations include, among others, availability and costs of financing needed in the future, changes in equity markets, delays in the development of projects, and ability to predict or counteract potential impact of COVID-19 coronavirus on factors relevant to the Company's business. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS PRESS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/120839